Veterans Coordinated Community Care (3C) Study (3C)
Suicide
About this trial
This is an interventional prevention trial for Suicide focused on measuring Veterans, Suicide Prevention, Behavioral Symptoms, Case Management
Eligibility Criteria
Inclusion Criteria:
- Inpatient Veteran at high-risk for post-discharge suicide (as flagged by the study's validated prediction model)
- 18 years or older
- Access to a telephone after discharge.
Exclusion Criteria:
- Impaired decision-making capacity
- Limited or no English language proficiency
- Terminal illness
Sites / Locations
- Central Arkansas Veterans Healthcare SystemRecruiting
- VA Boston Healthcare SystemRecruiting
- Minneapolis VA Health Care SystemRecruiting
- VA St. Louis Health Care SystemRecruiting
- VA Pittsburgh Healthcare SystemRecruiting
- VA Tennessee Valley Health Care SystemRecruiting
- VA North Texas Healthcare SystemRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Coping Long Term with Active Suicide Program (CLASP)
Treatment As Usual (TAU)
The CLASP intervention is an adjunctive, telehealth-based behavioral intervention designed to reduce suicidal behavior among individuals at high risk for suicide going through periods of transition. CLASP is designed to intervene on four risk factor targets: ongoing treatment engagement, problem-solving, social and family support, and hopelessness. In addition to these general factors, the CLASP provider also has the flexibility to identify and target certain "patient-specific" risk factors (e.g., substance misuse) for intervention. CLASP will begin after completion of the baseline assessment, and will continue for 6 months post-discharge. CLASP will be comprised of: a) 3 initial sessions while participants are still inpatients (can occur post-discharge if needed); b) 12 brief telehealth sessions over 6-months post-discharge; c) 6 brief SO telehealth sessions.
Treatment As Usual (TAU) consists of unrestricted treatment provided as part of routine care in the Veterans Health Administration (VHA) following inpatient hospitalization. Study staff will provide no additional treatment in this arm.